相似文献
1
Sars-Cov-2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment.
Liver Int. 2022 Jun;42(6):1225-1228. doi: 10.1111/liv.15226.
2
SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?
J Am Soc Nephrol. 2022 Apr;33(4):869-870. doi: 10.1681/ASN.2021121566. Epub 2022 Feb 14.
3
Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.
Liver Int. 2022 Aug;42(8):1872-1878. doi: 10.1111/liv.15258. Epub 2022 Apr 2.
4
Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.
Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101743. doi: 10.1016/j.clinre.2021.101743. Epub 2021 Jun 16.
5
SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for.
Ann Hepatol. 2023 May-Jun;28(3):101081. doi: 10.1016/j.aohep.2023.101081. Epub 2023 Mar 5.
6
Vaccination against SARS-CoV-2 in liver transplant recipients: The game is still long and the outcome is uncertain.
Liver Int. 2022 Oct;42(10):2341. doi: 10.1111/liv.15369. Epub 2022 Jul 29.
7
Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination.
Clin Exp Nephrol. 2023 Jan;27(1):98-99. doi: 10.1007/s10157-022-02261-6. Epub 2022 Aug 5.
8
Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients.
Clin Gastroenterol Hepatol. 2022 Jul;20(7):1534-1541.e4. doi: 10.1016/j.cgh.2022.01.012. Epub 2022 Jan 20.
9
Real-world Impact of 2-dose SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
Transplantation. 2022 May 1;106(5):e279-e280. doi: 10.1097/TP.0000000000004081. Epub 2022 Mar 4.
10
Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.
Front Immunol. 2022 Jun 1;13:906225. doi: 10.3389/fimmu.2022.906225. eCollection 2022.
引用本文的文献
1
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients.
Viruses. 2024 Dec 19;16(12):1942. doi: 10.3390/v16121942.
2
Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave.
Viruses. 2023 Jan 20;15(2):297. doi: 10.3390/v15020297.
3
COVID-19-associated liver injury, role of drug therapy and management: a review.
Egypt Liver J. 2022;12(1):66. doi: 10.1186/s43066-022-00230-y. Epub 2022 Nov 23.
4
Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohort.
Emerg Microbes Infect. 2022 Dec;11(1):2636-2644. doi: 10.1080/22221751.2022.2136535.
本文引用的文献
1
Discordance Between SARS-CoV-2-specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients.
Transplant Direct. 2021 Nov 17;7(12):e794. doi: 10.1097/TXD.0000000000001246. eCollection 2021 Dec.
2
Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients.
Liver Int. 2022 Jan;42(1):180-186. doi: 10.1111/liv.15089. Epub 2021 Nov 17.
3
COVID-19 and digestive health: Implications for prevention, care and the use of COVID-19 vaccines in vulnerable patients.
United European Gastroenterol J. 2021 Nov;9(9):1091-1095. doi: 10.1002/ueg2.12173. Epub 2021 Oct 30.
4
Waning Immunity after the BNT162b2 Vaccine in Israel.
N Engl J Med. 2021 Dec 9;385(24):e85. doi: 10.1056/NEJMoa2114228. Epub 2021 Oct 27.
5
Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS).
J Hepatol. 2022 Feb;76(2):364-370. doi: 10.1016/j.jhep.2021.09.041. Epub 2021 Oct 13.
6
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.
Nat Med. 2021 Nov;27(11):2032-2040. doi: 10.1038/s41591-021-01540-1. Epub 2021 Sep 29.
7
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients.
Clin Gastroenterol Hepatol. 2022 Jan;20(1):162-172.e9. doi: 10.1016/j.cgh.2021.09.003. Epub 2021 Sep 9.
8
Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients.
Liver Transpl. 2021 Dec;27(12):1852-1856. doi: 10.1002/lt.26273. Epub 2021 Sep 16.
9
Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
J Hepatol. 2022 Jan;76(1):237-239. doi: 10.1016/j.jhep.2021.07.034. Epub 2021 Aug 3.
10
Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients-A Single-Center Experience.
Vaccines (Basel). 2021 Jul 4;9(7):738. doi: 10.3390/vaccines9070738.
Zotero 插件